1. Jiao K, Wang C, Liao M, Ma J, Kang D*, Tang W*, Tucker JD*,Ma W*. A differentiated digital intervention to improve antiretroviral therapy adherence among men who have sex with men living with HIV in China: a randomized controlled trial. BMC Med. 2022 Oct 10;20(1):341. doi:10.1186/s12916-022-02538-3. PMID: 36210434.
2. Li C, Zhao Z, Yan Y, Liu Q,Zhao Q*, Ma W*. Short-term effects of tropical cyclones on the incidence of dengue: a time-series study in Guangzhou, China. Parasit Vectors. 2022 Oct 6;15(1):358. doi: 10.1186/s13071-022-05486-2. PMID: 36203178; PMCID: PMC9535872.
3. Cheng C, Li Y,Ma W*, Jia C*. Trajectories of waist circumference during young adulthood and incident hypertension: the China Health and Nutrition Survey. J Hum Hypertens. 2022 Aug;36(8):767-774. doi: 10.1038/s41371-021-00563-y.
4. Zhang AR, Li XL, Wang T, Liu K, Liu MJ, Zhang WH, Zhao GP, Chen JJ, Zhang XA, Miao D,Ma W*, Fang LQ*, Yang Y*, Liu W*. Ecology of Middle East respiratory syndrome coronavirus, 2012-2020: A machine learning modelling analysis. 2022;69:e2122–e21. doi: 10.1111/tbed.14548. PMID: 35366384
5. Jiao K, Wei R, Li H, Chow EPF, Piqueiras E, Lewis T, Xu Z, Ren C,Ma W*. HIV testing frequency and associated factors among five key populations in ten cities of China: a cross-sectional study. BMC Infect Dis. 2022 Feb 28;22(1):195. doi: 10.1186/s12879-022-07189-6. PMID: 35227217; PMCID: PMC8883696.
6. Jiao K, Li H, Zhang D, Jiang Z, Lin Y, Liu X, Xu H, Yan X, Tang H,Ma W*. Drug users' awareness of and willingness to use HIV non-occupational post-exposure prophylaxis (nPEP) services in China: a mixed methods study. BMC Infect Dis. 2022 Feb 14;22(1):151. doi: 10.1186/s12879-022-07106-x. PMID: 35164694; PMCID: PMC8842954.
7. Qi Q, Jiang B,Ma W*, Marley G. Trend Analysis and Spatial Distribution of Meteorological Disaster Losses in China, 2004–2015.Atmosphere. 2022; 13(2):208. https://doi.org/10.3390/atmos13020208
8. Li C, Zhao Q, Zhao Z, Liu Q,Ma W*. The association between tropical cyclones and dengue fever in the Pearl River Delta, China during 2013-2018: A time-stratified case-crossover study Tropical cyclones and dengue fever. PLoS Negl Trop Dis. 2021 Sep 9;15(9):e0009776. doi: 10.1371/journal.pntd.0009776. PMID: 34499666.
9. Li H, Wei R, Piqueiras E, Chow EPF, Jiao K, Lewis T,Ma W*. HIV non-occupational postexposure prophylaxis (nPEP) usage among five key populations in China. Sex Transm Infect. 2021;97:411–413. doi: 10.1136/sextrans-2020-054791.
10. Wang L, Huai P, Jiao K, Liu Y, Hua Y, Liu X, Wei C*,Ma W*. Awareness of and barriers to using non-occupational post-exposure prophylaxis among male clients of female sex workers in two cities of China: a qualitative study. Sex Health. 2021 Jul;18(3):239-247. doi: 10.1071/SH20203.
11. Zhang AR, Shi WQ, Liu K, Li XL, Liu MJ, Zhang WH, Zhao GP, Chen JJ, Zhang XA, Miao D,Ma W*, Liu W*, Yang Y*, Fang LQ*. Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012-2020. Infect Dis Poverty. 2021 May 8;10(1):66. doi: 10.1186/s40249-021-00853-0. PMID: 33964965; PMCID: PMC8105704.
12. Lin Y, Li C, Wang L, Jiao K, Ma W*. The mediated effect of HIV risk perception in the relationship between peer education and HIV testing uptake among three key populations in China. AIDS Res Ther. 2021 Mar 25;18(1):8. doi: 10.1186/s12981-021-00334-2.
13. Li H, Wei R, Ong JJ, Kim E, Weinstein TL, Ning X,Ma W*. Examining potential effects of non-occupational post-exposure prophylaxis (nPEP) on sexual behaviors of Chinese men who have sex with men: a cross-sectional study. BMC Public Health. 2021 Jan 26;21(1):221. doi: 10.1186/s12889-021-10283-0.
14. Li H, Piqueiras E, Chow EPF, Jiao K, Lewis T,Ma W*.HIV non-occupational post-exposure prophylaxis (nPEP) awareness and promotion among five key populations in China: A cross-sectional study. The Lancet Regional Health - Western Pacific. 2021;7:100086.
15. Ren C, Tucker JD, Tang W, Tao X, Liao M, Wang G, Jiao K, Xu Z, Zhao Z, Yan Y, Lin Y, Li C, Wang L, Li Y, Kang D,Ma W*. Digital crowdsourced intervention to promote HIV testing among MSM in China: study protocol for a cluster randomized controlled trial. Trials 21, 931 (2020).